BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9556786)

  • 1. Antiestrogen therapy: uncertainties and risk assessment.
    Smith LL; White IN
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.
    Hemminki K; Rajaniemi H; Lindahl B; Moberger B
    Cancer Res; 1996 Oct; 56(19):4374-7. PubMed ID: 8813128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tamoxifen dilemma.
    White IN
    Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    O'Regan RM; Cisneros A; England GM; MacGregor JI; Muenzner HD; Assikis VJ; Bilimoria MM; Piette M; Dragan YP; Pitot HC; Chatterton R; Jordan VC
    J Natl Cancer Inst; 1998 Oct; 90(20):1552-8. PubMed ID: 9790548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tamoxifen and breast cancer: is everything known already?].
    Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
    Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity of antiestrogens.
    Hirsimäki P; Aaltonen A; Mäntylä E
    Breast J; 2002; 8(2):92-6. PubMed ID: 11896754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    Williams GM
    J Natl Cancer Inst; 1999 Apr; 91(8):722-3. PubMed ID: 10218512
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen and secondary tumours. An update.
    Wilking N; Isaksson E; von Schoultz E
    Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    Mäenpää J; Ellmén J; Pasanen T; Kaukonen M
    J Natl Cancer Inst; 1999 Jun; 91(11):972-3. PubMed ID: 10359551
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and the uterus.
    Vergote I; Neven P; Vanderick G; van Dam P; Van Belle Y; De Sutter Ph; De Prins F; De Muylder X; Claerhout J; Campo R; Albertyn G
    Eur J Cancer; 1998 Aug; 34 Suppl 4():S1-3. PubMed ID: 9917139
    [No Abstract]   [Full Text] [Related]  

  • 15. Status of antiestrogen breast cancer prevention trials.
    Powles TJ
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
    Brodie A; Lu Q; Liu Y; Long B; Wang JP; Yue W
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):36-40. PubMed ID: 9556790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and the uterus. Proceedings of an international meeting. Brussels, Belgium, 12-13 December 1997.
    Eur J Cancer; 1998 Aug; 34 Suppl 4():S1-67. PubMed ID: 9887891
    [No Abstract]   [Full Text] [Related]  

  • 18. Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.
    Bertelli G; Queirolo P; Vecchio S; Angiolini C; Bergaglio M; Del Mastro L; Signorini A; Valenzano M; Venturini M
    Anticancer Res; 2000; 20(5C):3659-61. PubMed ID: 11268435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and the endometrium.
    Barakat RR
    Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.